表紙:PCR - 市場規模・シェア・動向分析:2021年~2028年
市場調査レポート
商品コード
1028493

PCR - 市場規模・シェア・動向分析:2021年~2028年

Polymerase Chain Reaction Market Size, Share & Trends Analysis Report By Type, By Product (Instruments, Consumables & Reagents), By Application, By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 170 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.12円
PCR - 市場規模・シェア・動向分析:2021年~2028年
出版日: 2021年09月01日
発行: Grand View Research, Inc.
ページ情報: 英文 170 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のPCRの市場規模は、2028年までに253億米ドルに達し、2021年~2028年のCAGRで0.9%の成長が予測されています。

この背景には、迅速な診断検査の需要の増加と技術の進歩があります。

当レポートでは、世界のPCR市場について調査分析し、市場概要、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 PCR市場 - 業界の見通し

  • 市場系統の見通し
  • 普及率と成長率の見通しマッピング
  • 市場力学
  • SWOT分析:要因別
  • 業界分析 - ポーターのファイブフォース分析
  • 償還・規制シナリオ
  • 主要取引と戦略的提携

第4章 PCR市場分析:タイプ別

  • PCR市場:タイプ別の分析
  • 従来型PCR
  • その他

第5章 PCR市場分析:製品別

  • PCR市場:製品別の分析
  • 消耗品・試薬
  • 機器
  • ソフトウェア・サービス

第6章 PCR市場分析:用途別

  • PCR市場:用途別の分析
  • 医学
  • 非医学

第7章 PCR市場分析:地域別

  • 市場シェア分析:国別

第8章 PCR市場:競合分析

  • 最近の動向と影響分析:主要な市場企業別
  • 企業の分類
  • ベンダー情勢
  • 公開企業
  • 非公開企業
  • 地域のネットワークマップ
  • 日本、オーストラリア、韓国、インド、シンガポール、欧州におけるPCR消耗品/酵素の主要地域/地元の競合企業
  • 企業プロファイル
    • Abbott
    • Qiagen
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Cytiva (GE Healthcare)
    • bioMerieux SA
    • F. Hoffmann-La Roche Ltd.
    • Fluidigm Corporation
    • STILLA
    • Microsynth AG
    • JN Medsys
    • Danaher Corporation
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Incidence of Diseases
  • Table 4 Comparison of Existing PCR with Plasmonic PCR
  • Table 5 Real-time RT-PCR kits with EUA for COVID-19
  • Table 6 PCR systems with EUA for COVID-19
  • Table 7 North America PCR Market, By Country, 2017 - 2028 (USD Million)
  • Table 8 North America PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 9 North America PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 10 North America PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 11 North America Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 12 North America Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 13 North America Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 14 U.S. PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 15 U.S. PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 16 U.S. PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 17 U.S. Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 18 U.S. Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 19 U.S. Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 20 Canada PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 21 Canada PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 22 Canada PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 23 Canada Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 24 Canada Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 25 Canada Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 26 Europe PCR Market, By Country, 2017 - 2028 (USD Million)
  • Table 27 Europe PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 28 Europe PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 29 Europe PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 30 Europe Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 31 Europe Clinical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 32 Europe Non-Medical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 33 Germany PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 34 Germany PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 35 Germany PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 36 Germany Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 37 Germany Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 38 Germany Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 39 U.K. PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 40 U.K PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 41 U.K. PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 42 U.K. Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 43 U.K. Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 44 U.K. Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 45 France PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 46 France PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 47 France PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 48 France Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 49 France Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 50 France Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 51 Italy PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 52 Italy PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 53 Italy PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 54 Italy Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 55 Italy Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 56 Italy Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 57 Spain PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 58 Spain PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 59 Spain PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 60 Spain Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 61 Spain Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 62 Spain Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 63 Asia Pacific PCR Market, By Country, 2017 - 2028 (USD Million)
  • Table 64 Asia Pacific PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 65 Asia Pacific PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 66 Asia Pacific PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 67 Asia Pacific Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 68 Asia Pacific Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 69 Asia Pacific Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 70 Japan PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 71 Japan PCR Market, By Product 2017 - 2028 (USD Million)
  • Table 72 Japan PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 73 Japan Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 74 Japan Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 75 Japan Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 76 China PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 77 China PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 78 China PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 79 China Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 80 China Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 81 China Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 82 India PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 83 India PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 84 India PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 85 India Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 86 India Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 87 India Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 88 Australia PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 89 Australia PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 90 Australia PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 91 Australia Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 92 Australia Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 93 Australia Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 94 South Korea PCR Market, By Type 2017 - 2028 (USD Million)
  • Table 95 South Korea PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 96 South Korea PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 97 South Korea Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 98 South Korea Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 99 South Korea Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 100 Latin America PCR Market, By Country, 2017 - 2028 (USD Million)
  • Table 101 Latin America PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 102 Latin America PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 103 Latin America PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 104 LatinAmerica Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 105 Latin America Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 106 Latin America Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 107 Brazil PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 108 Brazil PCR Market, By Product 2017 - 2028 (USD Million)
  • Table 109 Brazil PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 110 Brazil Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 111 Brazil Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 112 Brazil Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 113 Mexico PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 114 Mexico PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 115 Mexico PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 116 Mexico Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 117 Mexico Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 118 Mexico Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 119 Argentina PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 120 Argentina PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 121 Argentina PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 122 Argentina Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 123 Argentina Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 124 Argentina Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 125 Middle East & Africa PCR Market, By Country, 2017 - 2028 (USD Million)
  • Table 126 Middle East & Africa PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 127 Middle East & Africa PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 128 Middle East & Africa PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 129 Middle East & Africa Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 130 Middle East & Africa Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 131 Middle East & Africa Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 132 Saudi Arabia PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 133 Saudi Arabia PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 134 Saudi Arabia PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 135 Saudi Arabia Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 136 Saudi Arabia Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 137 Saudi Arabia Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 138 South Africa PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 139 South Africa PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 140 South Africa PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 141 South Africa Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 142 South Africa Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 143 South Africa Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 144 UAE PCR Market, By Type, 2017 - 2028 (USD Million)
  • Table 145 UAE PCR Market, By Product, 2017 - 2028 (USD Million)
  • Table 146 UAE PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 147 UAE Medical PCR Market, By Application, 2017 - 2028 (USD Million)
  • Table 148 UAE Clinical PCR Medical Market, By Application, 2017 - 2028 (USD Million)
  • Table 149 UAE Non-Medical PCR Market, By Application, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 PCR market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 PCR market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2020, USD Million
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 PCR market driver impact
  • Fig. 14 PCR market restraint impact
  • Fig. 15 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 PCR market - Unmet needs analysis
  • Fig. 19 Consumer behavior analysis
  • Fig. 20 PCR market: Type outlook and key takeaways
  • Fig. 21 PCR market: Type movement analysis & market share 2020 & 2028
  • Fig. 22 Conventional PCR market estimates and forecast, 2017 - 2028(USD Million)
  • Fig. 23 Others market estimates and forecast, 2017 - 2028(USD Million)
  • Fig. 24 PCR market: Product outlook and key takeaways
  • Fig. 25 PCR market: Product movement analysis & market share 2020 & 2028
  • Fig. 26 Consumables & reagents market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 27 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 28 Software & services market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 29 PCR market: Application outlook and key takeaways
  • Fig. 30 PCR market: Application movement analysis & market share 2020 & 2028
  • Fig. 31 Medical market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 32 Clinical market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 33 Pathogen testing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 34 Oncology testing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 35 Blood screening market estimates and forecast, 2017 - 2028 (USD million)
  • Fig. 36 Others market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 37 Research market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 38 Forensics and others market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 39 Non-medical market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 40 Food market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 41 Others market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 42 PCR market: Regional outlook and key takeaways
  • Fig. 43 Regional outlook, 2020 & 2028
  • Fig. 44 North America
  • Fig. 45 North America market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 46 U.S.
  • Fig. 47 U.S. market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 48 Canada
  • Fig. 49 Canada market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 50 Europe
  • Fig. 51 Europe market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 52 U.K.
  • Fig. 53 U.K. market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 56 France
  • Fig. 57 France market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 58 Italy
  • Fig. 59 Italy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 60 Spain
  • Fig. 61 Spain market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecast, 2017 - 2028(USD Million)
  • Fig. 66 China
  • Fig. 67 China market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 68 India
  • Fig. 69 India market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 74 Latin America
  • Fig. 75 Latin America market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 76 Brazil
  • Fig. 77 Brazil market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 78 Mexico
  • Fig. 79 Mexico market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 80 Argentina
  • Fig. 81 Argentina market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 82 Middle East & Africa
  • Fig. 83 MEA market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 84 South Africa
  • Fig. 85 South Africa market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 86 Saudi Arabia
  • Fig. 87 Saudi Arabia market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 88 UAE
  • Fig. 89 UAE market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 90 Ansoff Matrix
  • Fig. 91 Market differentiators
  • Fig. 92 Key company market share analysis, 2020
  • Fig. 93 Company market position analysis
  • Fig. 94 Company market position analysis
  • Fig. 95 Competitive dashboard analysis
  • Fig. 96 Regional network map
目次
Product Code: GVR-4-68039-188-0

Polymerase Chain Reaction Market Growth & Trends

The global polymerase chain reaction market size is expected to reach USD 25.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 0.9% from 2021 to 2028. This is driven by an increase in demand for rapid diagnostic tests and technological advancements.

Key players operating in the market are focusing on introducing novel and technologically advanced devices for PCR tests. For instance, in July 2017, Bio-Rad Laboratories launched droplet digital PCR Genome Edit Detection Assays to quantify the efficiency of CRISPR-Cas9 or any other genome using the technology of Bio-Rad's droplet digital polymerase chain reaction. This technology has gained prominence over the past few years.

Furthermore, the COVID-19 outbreak has increased the growth rate of dPCR technology. Several types of research activities are being conducted for proving the accuracy of the dPCR test. For instance, in March 2020, researchers of the Center for Advanced Measurement Science worked with Chongqing University in collaboration with the Centers for Disease Prevention and Control of Wuhan and Beijing for detecting the sensitivity of dPCR kits. In addition, two more studies were conducted in China that suggested improved sensitivity as compared to gold standard RT-qPCR. Moreover, in March 2020, Bio-Rad Laboratories developed a dPCR test for the detection of the SARS-CoV-2 virus.

Various research initiatives being undertaken coupled with increasing collaborations between companies for the development of tests are factors anticipated to drive the growth of the segment. In May 2020, Xiamen University, in collaboration with the Chinese University of Hong Kong and University of Connecticut, was engaged in the development of an experimental procedure for developing and validating a qPCR assay for the detection of Symbiodiniaceae genera. Furthermore, sxtA-based qPCR tests were proved to be effective against Alexandrium catenella in 2019.

Government initiatives undertaken to boost testing capacity are expected to drive the market. For instance, in September 2020, the National Institutes of Health offered USD 129.3 million under the Rapid Acceleration of Diagnostics (RADx) initiative to drive manufacturing and usage of RT-PCR. The growing number of tests conducted by governments to counter the COVID-19 pandemic is expected to act as a driver for qPCR and dPCR market. For instance, Iceland has conducted 135 tests per 1,000 population.

The introduction of novel PCR such as plasmonic PCR in the PoC diagnostics platform is expected to be a disruptive technology, as existing PCR platforms are slow, expensive, and energy costly. Therefore, the development of lower-cost PoC technology with high accuracy is expected to reduce the procurement cost for medical use and overall laboratory cost of a patient in countries of Asia Pacific, North America, and Europe.

Moreover, initiatives are undertaken by key players to enhance their product portfolios and global presence. For instance, in September 2020, Qiagen acquired NeuMoDx Molecular, Inc. for USD 248 million. The acquisition is anticipated to boost Qiagen's PCR portfolio and enhance its global presence as well as customer access.

Polymerase Chain Reaction Market Report Highlights

In 2020, the others type segment which includes real-time PCR (qPCR), digital PCR (dPCR), multiplex, and ultrafast PCR held a majority of the share. Increasing demand and high adoption due to its ability to detect pathogens and infection rapidly, automation, and cost-effective are factors supporting segment growth

The consumables and reagents segment dominated the market in 2020 owing to increased demand for consumables and reagents to meet the heightened testing demands during the pandemic

The medical segment held the largest revenue share in 2020 due to an increase in clinical testing along with rising research activities for DNA cloning, microbiome analysis, and gene expression

In Asia Pacific, the market is projected to witness the fastest growth during the forecast period owing to high-unmet needs and improving healthcare infrastructure

North America dominated the market in 2020 due to the presence of key players and rising initiatives to raise awareness among healthcare professionals and patients

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country wise market estimation using bottom up approach
      • 1.6.1.3 Approach 3: Country wise market estimation using top down approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 Key KoL Responses
  • 1.10 Market Share Calculations
  • 1.11 List of Secondary Sources
  • 1.12 Objectives
    • 1.12.1 Objective 1:
    • 1.12.2 Objective 2:
  • 1.13 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 PCR Market - Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
      • 3.3.1.2 Technological advancements in PCR
      • 3.3.1.3 Implementation of MIQE guidelines
      • 3.3.1.4 Increasing demand for rapid diagnostic tests and growing adoption of PCR technologies
      • 3.3.1.5 Increasing number of CROs and forensic & research laboratories
      • 3.3.1.6 Increasing demand for prenatal genetic testing procedures
      • 3.3.1.7 Outbreak of COVID-19
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 High qPCR device costs
      • 3.3.2.2 Stringent regulatory policies
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions
      • 3.7.5.1 Market entry strategies
    • 3.7.6 Unmet Need Analysis
      • 3.7.6.1 Need for rapid diagnosis
      • 3.7.6.2 Affordability
      • 3.7.6.3 Limited scope of pathogen detection
    • 3.7.7 Change in market dynamics after the launch of novel PCR devices
      • 3.7.7.1 Medical
      • 3.7.7.2 Non-Medical
    • 3.7.8 Comparison of existing PCR with Plasmonic PCR
      • 3.7.8.1 Potential for COVID-19
    • 3.7.9 Consumer Behavior Analysis

Chapter 4 PCR Market Analysis: Type Scope, 2017 - 2028 (Revenue, USD Million)

  • 4.1 PCR Market: Type Movement Analysis
  • 4.2 Conventional PCR
    • 4.2.1 Conventional PCR market estimates and forecast, 2017 - 2028 (USD million)
  • 4.3 Others
    • 4.3.1 Others market estimates and forecast, 2017 - 2028 (USD million)

Chapter 5 PCR Market Analysis: Product Scope, 2017 - 2028 (Revenue, USD Million)

  • 5.1 PCR Market: Products Movement Analysis
  • 5.2 Consumables & Reagents
    • 5.2.1 Consumables & reagents market estimates and forecast, 2017 - 2028 (USD Million)
  • 5.3 Instruments
    • 5.3.1 Instruments market estimates and forecast, 2017 - 2028 (USD Million)
  • 5.4 Software & Services
    • 5.4.1 Software & services market estimates and forecast, 2017 - 2028 (USD Million)

Chapter 6 PCR Market Analysis: Application Scope, 2017 - 2028 (Revenue, USD Million)

  • 6.1 PCR Market: Application Movement Analysis
  • 6.2 Medical
    • 6.2.1 Medical market estimates and forecast, 2017 - 2028 (USD million)
    • 6.2.2 Clinical
    • 6.2.3 Clinical market estimates and forecast, 2017 - 2028 (USD million)
      • 6.2.3.1 Pathogen Testing
      • 6.2.3.1.1 Pathogen testing market estimates and forecast, 2017 - 2028 (USD million)
      • 6.2.3.2 Oncology Testing
      • 6.2.3.2.1 Oncology testing market estimates and forecast, 2017 - 2028 (USD million)
      • 6.2.3.3 Blood Screening
      • 6.2.3.3.1 Blood screening market estimates and forecast, 2017 - 2028 (USD million)
      • 6.2.3.4 Others
      • 6.2.3.4.1 Others market estimates and forecast, 2017 - 2028 (USD million)
    • 6.2.4 Research
      • 6.2.4.1 Research market estimates and forecast, 2017 - 2028 (USD million)
    • 6.2.5 Forensics and Others
      • 6.2.5.1 Forensics and others market estimates and forecast, 2017 - 2028 (USD million)
  • 6.3 Non-medical
    • 6.3.1 Non-medical market estimates and forecast, 2017 - 2028 (USD million)
    • 6.3.2 Food
      • 6.3.2.1 Food market estimates and forecast, 2017 - 2028 (USD million)
    • 6.3.3 Others
      • 6.3.3.1 Others market estimates and forecast, 2017 - 2028 (USD million)

Chapter 7 PCR Market Analysis, Regional Scope, 2017 - 2028, (Revenue, USD Million)

  • 7.1 Market Share Analysis by Country, 2020 & 2028
    • 7.1.1 North America
      • 7.1.1.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 U.S. market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Canada market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.1.2 Europe
      • 7.1.2.1 Europe market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.2.2 U.K.
      • 7.1.2.2.1 U.K. market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Germany market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.2.4 France
      • 7.1.2.4.1 France market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.2.5 Italy
      • 7.1.2.5.1 Italy market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.2.6 Spain
      • 7.1.2.6.1 Spain market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.1.3 Asia Pacific
      • 7.1.3.1 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Japan market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.3.3 China
      • 7.1.3.3.1 China market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.3.4 India
      • 7.1.3.4.1 India market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.3.5 South Korea
      • 7.1.3.5.1 South Korea market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.3.6 Australia
      • 7.1.3.6.1 Australia market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.1.4 Latin America
      • 7.1.4.1 Latin America market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Brazil market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Mexico market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Argentina market estimates and forecast, 2017 - 2028 (USD Million)
    • 7.1.5 Middle East and Africa
      • 7.1.5.1 Middle East & Africa market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 South Africa market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2017 - 2028 (USD Million)
      • 7.1.5.4 UAE
      • 7.1.5.4.1 UAE market estimates and forecast, 2017 - 2028 (USD Million)

Chapter 8 PCR Market: Competitive Analysis

  • 8.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 8.1.1 Ansoff matrix`
  • 8.2 Company Categorization
    • 8.2.1 Innovators
      • 8.2.1.1 Market Differentiators
  • 8.3 Vendor Landscape
    • 8.3.1 List of key distributors and channel partners
    • 8.3.2 Key customers
    • 8.3.3 Key company market share analysis, 2020
  • 8.4 Public Companies
    • 8.4.1 Competitive dashboard analysis
  • 8.5 Private Companies
    • 8.5.1 List of key emerging companies
  • 8.6 Regional Network Map
  • 8.7 Key Regional/Local Competitors for PCR Consumables/Enzymes in Japan, Australia, Korea, India, Singapore, and Europe
  • 8.8 Company Profiles
    • 8.8.1 Abbott
      • 8.8.1.1 Company overview
      • 8.8.1.2 Financial performance
      • 8.8.1.3 Product benchmarking
      • 8.8.1.4 Strategic initiatives
    • 8.8.2 Qiagen
      • 8.8.2.1 Company overview
      • 8.8.2.2 Financial performance
      • 8.8.2.3 Product benchmarking
      • 8.8.2.4 Strategic initiatives
    • 8.8.3 Bio-Rad Laboratories, Inc.
      • 8.8.3.1 Company overview
      • 8.8.3.2 Financial performance
      • 8.8.3.3 Product benchmarking
      • 8.8.3.4 Strategic initiatives
    • 8.8.4 Agilent Technologies, Inc.
      • 8.8.4.1 Company overview
      • 8.8.4.2 Financial performance
      • 8.8.4.3 Product benchmarking
      • 8.8.4.4 Strategic initiatives
    • 8.8.5 Thermo Fisher Scientific, Inc.
      • 8.8.5.1 Company overview
      • 8.8.5.2 Affymetrix
      • 8.8.5.3 Company overview
      • 8.8.5.4 Financial performance
      • 8.8.5.5 Product benchmarking
      • 8.8.5.6 Strategic initiatives
    • 8.8.6 Cytiva (GE Healthcare)
      • 8.8.6.1 Company overview
      • 8.8.6.2 Financial performance
      • 8.8.6.3 Product benchmarking
      • 8.8.6.4 Strategic initiatives
    • 8.8.7 bioMerieux SA
      • 8.8.7.1 Company overview
      • 8.8.7.2 Financial performance
      • 8.8.7.3 Product benchmarking
      • 8.8.7.4 Strategic initiatives
    • 8.8.8 F. Hoffmann-La Roche Ltd.
      • 8.8.8.1 Company overview
      • 8.8.8.2 Financial performance
      • 8.8.8.3 Product benchmarking
      • 8.8.8.4 Strategic initiatives
    • 8.8.9 Fluidigm Corporation
      • 8.8.9.1 Company overview
      • 8.8.9.2 Financial performance
      • 8.8.9.3 Product benchmarking
      • 8.8.9.4 Strategic initiatives
    • 8.8.10 STILLA
      • 8.8.10.1 COMPANY OVERVIEW
      • 8.8.10.2 Product benchmarking
      • 8.8.10.3 Strategic initiatives
    • 8.8.11 Microsynth AG
      • 8.8.11.1 Company overview
      • 8.8.11.2 Product benchmarking
      • 8.8.11.3 Strategic initiatives
    • 8.8.12 JN Medsys
      • 8.8.12.1 Company overview
      • 8.8.12.2 Product benchmarking
      • 8.8.12.3 Strategic initiatives
    • 8.8.13 Danaher Corporation
      • 8.8.13.1 Company overview
      • 8.8.13.2 Cepheid
      • 8.8.13.3 Beckman Coulter
      • 8.8.13.4 Leica Biosystems
      • 8.8.13.5 Financial performance
      • 8.8.13.6 Product benchmarking
      • 8.8.13.7 Strategic initiatives